2023 MDA Conference: FDA Keynote Address On Genetic Therapy, Peter Marks MD PhD

preview_player
Показать описание
Detailed overview of the FDA's role in a broad array of therapies currently and in the pipeline for neuromuscular disease.
Рекомендации по теме